Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

Inclusion Criteria: * Patients will need a diagnosis established by a neurologist. Patients must be able to provide informed consent, or have a guardian who does. They must be able to travel to the site of treatment. Exclusion Criteria: * Patients were excluded from the trial if they were pregnant or had active cancer at the screening consultation.